Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

66 works

Work: Involving stemness factors to improve CAR T-cell-based cancer immunotherapy

  1. NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma

    Tobias Weiß, Michael Weller, Matthias Gückenberger +2

    Article20173 citations
    ABI

  2. Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme

    Amir R. Afshari, Ali Motamed‐Sanaye, Hamed Sabri +7

    Article20213 citations
    ABI

  3. Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines

    Edmund K. Moon, Liang‐Chuan S. Wang, Kheng Bekdache +4

    Article20172 citations
    ABI

  4. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity

    Zong Sheng Guo, Zuqiang Liu, David L. Bartlett

    Review article20142 citations
    ABI

  5. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

    Shashi Gujar, Jonathan Pol, Youra Kim +2

    Review article20172 citations
    ABI

  6. c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target

    Chenwei Li, Jingjiang Wu, Mark J. Hynes +5

    Article20112 citations
    ABI

  7. The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

    Markus Münz, Patrick A. Baeuerle, Olivier Gires

    Review article20092 citations
    ABI

  8. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells

    Amélie Montel‐Hagen, Christopher S. Seet, Suwen Li +11

    Article20192 citations
    ABI

  9. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

    Esther Drent, Renée Poels, Ruud Ruiter +9

    Article20192 citations
    ABI

  10. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

    Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai +17

    Article20212 citations
    ABI

  11. Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy

    Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour +5

    Review article20212 citations
    ABI

  12. Merkel cell carcinoma on the right calf in association with chronic lymphocytic leukemia: A case report

    Hamideh Mohammadzadeh, Sepideh Babaniamansour, Mohammadreza Majidi +3

    Article20212 citations
    ABI

  13. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer

    Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz +14

    Review article20232 citations
    ABI

  14. Untitled

    Other1 citations
    ABI

  15. Untitled

    Other1 citations
    ABI

  16. Untitled

    Other1 citations
    ABI

  17. Untitled

    Other1 citations
    ABI

  18. Untitled

    Other1 citations
    ABI

  19. Untitled

    Other1 citations
    ABI

  20. Untitled

    Other1 citations
    ABI

  21. Untitled

    Other1 citations
    ABI

  22. Untitled

    Other1 citations
    ABI

  23. Untitled

    Other1 citations
    ABI

  24. Untitled

    Other1 citations
    ABI

  25. Untitled

    Other1 citations
    ABI